| Variants in myelin regulatory factor (MYRF) cause autosomal dominant and syndromic nanophthalmos in humans and retinal degeneration in mice SJ Garnai, ML Brinkmeier, B Emery, TS Aleman, LC Pyle, B Veleva-Rotse, ... PLoS genetics 15 (5), e1008130, 2019 | 52 | 2019 |
| STRAD pseudokinases regulate axogenesis and LKB1 stability BO Veleva-Rotse, JL Smart, AF Baas, B Edmonds, Z Zhao, A Brown, ... Neural Development 9, 1-13, 2014 | 26 | 2014 |
| Expression of myeloid differentiation factor 88 in neurons is not requisite for the induction of sickness behavior by interleukin-1β TP Braun, AJ Grossberg, BO Veleva-Rotse, JE Maxson, M Szumowski, ... Journal of neuroinflammation 9, 1-13, 2012 | 25 | 2012 |
| Brain patterning perturbations following PTEN loss BO Veleva-Rotse, AP Barnes Frontiers in Molecular Neuroscience 7, 35, 2014 | 20 | 2014 |
| Genomic Ascertainment Cohort, Camper SA, Richards JE, Prasov L. Variants in myelin regulatory factor (MYRF) cause autosomal dominant and syndromic nanophthalmos in humans and … SJ Garnai, ML Brinkmeier, B Emery, TS Aleman, LC Pyle, B Veleva-Rotse, ... PLoS Genet 15, e1008130, 2019 | 5 | 2019 |
| Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to Reclassification I Keyzor, S Shohet, J Castelli, S Sitaraman, B Veleva-Rotse, JM Weimer, ... Biomolecules 13 (8), 1227, 2023 | 1 | 2023 |
| Prevalence of migalastat-amenable mutations in patients with Fabry disease from Brazil, Argentina and Colombia J Politei, AM Zarante, MH de Sa Pereira, V Lengoc, AA Loures-Vale, ... Molecular Genetics and Metabolism 141 (2), 108001, 2024 | | 2024 |
| Cardiac biomarkers in Fabry disease P Nandi, R Ellis, BO Veleva-Rotse, J Hiros, P Howard Molecular Genetics and Metabolism 141 (2), 107980, 2024 | | 2024 |
| Multiorgan involvement in females with Fabry disease: Results from two phase III trials and the followME registry P Nordbeck, DA Hughes, A Nowak, RJ Hopkin, BO Veleva-Rotse, ... Molecular Genetics and Metabolism 141 (2), 107985, 2024 | | 2024 |
| Clinical characteristics of female patients enrolled in the FollowME Fabry Pathfinders registry A Jovanovic, P Nordbeck, A Pisani, A Nowak, U Feldt-Rasmussen, ... Molecular Genetics and Metabolism 138 (2), 107173, 2023 | | 2023 |
| High prevalence of cardiac findings in individuals with Fabry disease identified via no-charge sponsored testing programs BO Veleva-Rotse, JD Giuliano, KL McPherson, AT Willcock, ... Molecular Genetics and Metabolism 138 (2), 107346, 2023 | | 2023 |
| Long-term multisystemic efficacy with migalastat in ERT-naive and ERT-experienced patients with amenable GLA variants RJ Hopkin, DG Bichet, G Sunder-Plassmann, K Nicholls, I Olivotto, ... Molecular Genetics and Metabolism 135 (2), S56, 2022 | | 2022 |
| Variants in myelin regulatory factor (MYRF) cause autosomal dominant nanophthalmos. L Prasov, SJ Garnai, M Brinkmeier, B Emery, TS Aleman, LC Pyle, ... Investigative Ophthalmology & Visual Science 60 (9), 5420-5420, 2019 | | 2019 |
| Strad Pseudokinases are Critical in Embroyonic Brain Development and in Regulating LKB1 Stability: A Dissertation BO Veleva-Rotse Oregon Health & Science University, 2015 | | 2015 |
| Strad pseudokinases are critical in embroyonic brain development and in regulating LKB1 stability BO Veleva-Rotse | | 2015 |
| Expression of myeloid differentiation factor 88 in neurons is not requisite for the induction of sickness behavior by interleukin-1β DL Marks, AP Barnes, M Szumowski, JE Maxson, BO Veleva-Rotse, ... | | 2012 |
| Sei registrato? D Bratkovic, M Tchan, K Nicholls, R Hopkin, G Sunder-Plassmann, ... Age 30, 61.2, 0 | | |
Aaron Grossberg MD, PhDDepartment of Radiation Medicine, CEDAR, BCCPC, Oregon Health & Science UniversityVerified email at ohsu.edu
